Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642; and David H. Smith Center for Vaccine Biology and Imunology, University of Rochester Medical Center, Rochester, NY 14642.
Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642; and David H. Smith Center for Vaccine Biology and Imunology, University of Rochester Medical Center, Rochester, NY 14642
J Immunol. 2014 Jun 15;192(12):6062-70. doi: 10.4049/jimmunol.1303348. Epub 2014 May 12.
Elmo1 and Elmo2 are highly homologous cytoplasmic adaptor proteins that interact with Dock family guanine nucleotide exchange factors to promote activation of the small GTPase Rac. In T lymphocytes, Dock2 is essential for CCR7- and CXCR4-dependent Rac activation and chemotaxis, but the role of Elmo proteins in regulating Dock2 function in primary T cells is not known. In this article, we show that endogenous Elmo1, but not Elmo2, interacts constitutively with Dock2 in mouse and human primary T cells. CD4(+) T cells from Elmo1(-/-) mice were profoundly impaired in polarization, Rac activation, and chemotaxis in response to CCR7 and CXCR4 stimulation. Transfection of full-length Elmo1, but not Elmo2 or a Dock2-binding mutant of Elmo1, rescued defective migration of Elmo1(-/-) T cells. Interestingly, Dock2 protein levels were reduced by 4-fold in Elmo1(-/-) lymphocytes despite normal levels of Dock2 mRNA. Dock2 polyubiquitination was increased in Elmo1(-/-) T cells, and treatment with proteasome inhibitors partially restored Dock2 levels in Elmo1(-/-) T cells. Finally, we show that Dock2 is directly ubiquitinated in CD4(+) T cells and that Elmo1 expression in heterologous cells inhibits ubiquitination of Dock2. Taken together, these findings reveal a previously unknown, nonredundant role for Elmo1 in controlling Dock2 levels and Dock2-dependent T cell migration in primary lymphocytes. Inhibition of Dock2 has therapeutic potential as a means to control recruitment of pathogenic lymphocytes in diseased tissues. This work provides valuable insights into the molecular regulation of Dock2 by Elmo1 that can be used to design improved inhibitors that target the Elmo-Dock-Rac signaling complex.
Elmo1 和 Elmo2 是高度同源的细胞质衔接蛋白,它们与 Dock 家族鸟嘌呤核苷酸交换因子相互作用,促进小 GTPase Rac 的激活。在 T 淋巴细胞中,Dock2 对于 CCR7 和 CXCR4 依赖性 Rac 激活和趋化作用是必需的,但 Elmo 蛋白在调节原代 T 细胞中 Dock2 功能中的作用尚不清楚。在本文中,我们显示内源性 Elmo1(但不是 Elmo2)在小鼠和人原代 T 细胞中与 Dock2 组成性相互作用。Elmo1(-/-) 小鼠的 CD4(+) T 细胞在极化、Rac 激活和对 CCR7 和 CXCR4 刺激的趋化作用方面受到严重损害。全长 Elmo1 的转染,但不是 Elmo2 或 Elmo1 的 Dock2 结合突变体,可挽救 Elmo1(-/-) T 细胞迁移缺陷。有趣的是,尽管 Dock2 mRNA 水平正常,但 Elmo1(-/-) 淋巴细胞中的 Dock2 蛋白水平降低了 4 倍。Elmo1(-/-) T 细胞中的 Dock2 多泛素化增加,用蛋白酶体抑制剂处理可部分恢复 Elmo1(-/-) T 细胞中的 Dock2 水平。最后,我们表明 Dock2 在 CD4(+) T 细胞中被直接泛素化,并且 Elmo1 在异源细胞中的表达抑制 Dock2 的泛素化。总之,这些发现揭示了 Elmo1 在控制原代淋巴细胞中 Dock2 水平和 Dock2 依赖性 T 细胞迁移中的以前未知的、非冗余作用。抑制 Dock2 具有作为控制疾病组织中致病性淋巴细胞募集的治疗潜力。这项工作提供了关于 Elmo1 对 Dock2 调控的分子机制的有价值的见解,可用于设计靶向 Elmo-Dock-Rac 信号复合物的改进抑制剂。